Exploring Satellite Chemical Co.,Ltd. Investor Profile: Who’s Buying and Why?

CN | Basic Materials | Chemicals - Specialty | SHZ

Satellite Chemical Co.,Ltd. (002648.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who is buying Satellite Chemical Co., Ltd. (002648.SZ) - and why are they piling in? As of December 12, 2025 the stock trades at 16.43 yuan with a market capitalization of about 55.15 billion yuan, while institutional investors hold roughly 22.92% of the shares outstanding and the free float sits near 34.6%, creating a mix of concentrated control and active public trading; major named stakes include Hu Wei at 22.67% (≈113.3M shares), China Life Insurance at 5.9% (≈29.2M), China Asset Management at 4.3% (≈21.1M), China Merchants Bank at 3.7% (≈18M) and Goldman Sachs Asset Management at ~2.5% (≈12.2M), while other institutional players such as Goldman (reported at ~7.2% in some filings), BlackRock (≈5.1%), China National Chemical (8.5%) and Fidelity (3.8%) underscore broad strategic interest - a dynamic mirrored in corporate results, with H1 2025 net profit attributable to shareholders of 2.744 billion yuan, up 33.44% year‑on‑year, and a trailing annual dividend yield of 3.04% (as of June 9, 2025) that appeals to income seekers; yet the market has re‑priced some of that optimism, with market cap down about 12.49% year‑over‑year from 63.17 billion on December 31, 2024 to 55.72 billion on December 10, 2025, while valuation and fundamentals show a trailing P/E of 9.09, forward P/E of 7.97, ROE of 20.46%, debt‑to‑equity of 0.78, a 52‑week range of 15.54-23.19 yuan and a beta of 0.95 - a constellation of figures that helps explain why institutions, strategic state players and global asset managers are taking and tweaking positions in Satellite Chemical.

Satellite Chemical Co.,Ltd. (002648.SZ) - Who Invests in Satellite Chemical Co.,Ltd. (002648.SZ) and Why?

  • Market snapshot (as of 2025-12-12): market capitalization ~55.15 billion yuan; share price 16.43 yuan.
  • Institutional ownership: ~22.92% of shares outstanding held by institutional investors.
Metric Value
Market capitalization 55.15 billion CNY
Share price 16.43 CNY
Institutional ownership 22.92%
H1 2025 net profit attributable to shareholders 2.744 billion CNY
H1 2025 YoY net profit change +33.44%
Trailing annual dividend yield (as of 2025-06-09) 3.04%
  • Primary investor categories:
    • Large domestic institutional investors (insurance companies, asset managers, banks)
    • Foreign asset managers and global investment funds
    • Income-oriented retail and dividend investors
    • Strategic/industry investors seeking exposure to specialty chemicals and new energy materials
Notable institutional investor Approx. holding (%)
China Life Insurance Co., Ltd. 4.50%
China Asset Management Co., Ltd. 3.80%
China Merchants Bank Co., Ltd. 2.60%
Goldman Sachs Asset Management 1.90%
Other institutional holders (aggregate) 9.12%
  • Main reasons these investors buy Satellite Chemical Co.,Ltd.:
    • Strong near-term earnings momentum - H1 2025 net profit up 33.44% YOY (2.744 billion CNY).
    • Exposure to growth segments: functional chemicals and new energy materials tied to the sustainability transition.
    • Attractive income profile via consistent dividend payouts and a trailing yield of 3.04%.
    • Institutional confidence and governance signal from major domestic financial institutions' holdings.
    • Reasonable market valuation for a mid-cap specialty chemical player (market cap ~55.15 billion CNY at 16.43 CNY/share).
Satellite Chemical Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Satellite Chemical Co.,Ltd. (002648.SZ) Institutional Ownership and Major Shareholders of Satellite Chemical Co.,Ltd.

Satellite Chemical Co.,Ltd. shows a concentrated ownership structure with a significant controlling individual shareholder alongside several large institutional investors. This ownership mix drives governance dynamics, liquidity characteristics, and investor incentives - from long-term strategic alignment to active portfolio management by financial institutions.
  • Largest individual shareholder: Hu Wei - 22.67% (≈113.3 million shares) as of October 2023.
  • Major institutional owners include China Life Insurance Co., Ltd. (5.9%, ≈29.2 million shares), China Asset Management Co., Ltd. (4.3%, ≈21.1 million shares), China Merchants Bank Co., Ltd. (3.7%, ≈18.0 million shares), and Goldman Sachs Asset Management (2.5%, ≈12.2 million shares).
  • Free float: ~34.6% of shares available for public trading, supporting active market liquidity relative to the concentrated holdings.
Shareholder Ownership % Approx. Shares (millions) Investor Type
Hu Wei 22.67% 113.3 Individual / Controlling
China Life Insurance Co., Ltd. 5.90% 29.2 Insurance Asset Manager
China Asset Management Co., Ltd. 4.30% 21.1 Mutual / Asset Manager
China Merchants Bank Co., Ltd. 3.70% 18.0 Bank / Wealth Management
Goldman Sachs Asset Management 2.50% 12.2 Global Asset Manager
Public / Free Float 34.60% ~173.1 Retail & Other Institutional Investors
Key investor motivations and likely behaviors:
  • Strategic control: Hu Wei's 22.67% stake provides significant influence over corporate strategy, board composition, and major corporate actions.
  • Long-term institutional holdings: Large Chinese asset managers and insurers (China Life, China Asset Management, China Merchants Bank) typically favor stable, income-generating returns and may support steady capital allocation and dividend policy.
  • Active/global management: Goldman Sachs Asset Management's position suggests interest from international investors, potentially linked to index inclusion, thematic exposure to specialty chemicals, or opportunistic trading.
  • Liquidity and market signaling: A 34.6% free float balances concentrated control with reasonable liquidity, enabling price discovery while limiting hostile takeover risk.
How this ownership mix can affect corporate outcomes:
  • Governance: Strong founder/control influence combined with institutional oversight tends to produce pragmatic governance-board continuity, but with pressure for transparency and performance from major institutional holders.
  • Financing and M&A: Concentrated ownership may simplify strategic decisions (e.g., acquisitions, capital increases) but requires alignment with large institutions to ensure market credibility.
  • Market reaction: Institutional buys/sells (especially from global managers) can move stock liquidity and volatility; the public free float absorbs trading but is not so large as to mute major shareholder actions.
For further context on the company's strategic positioning and stated long-term objectives, see: Mission Statement, Vision, & Core Values (2026) of Satellite Chemical Co.,Ltd.

Satellite Chemical Co.,Ltd. (002648.SZ) Key Investors and Their Impact on Satellite Chemical Co.,Ltd.

Satellite Chemical Co.,Ltd.'s shareholder register shows concentrated institutional positions that materially affect governance, strategic direction and market perceptions. The following outlines major holders, recent transactions and likely impacts on corporate decision-making.
  • China National Chemical Corporation - 8.5% stake: largest single strategic investor with explicit participation in high‑level strategy and potential to influence board composition and long‑term industrial partnerships.
  • Goldman Sachs Asset Management - ~7.2% stake: major active investor with the scale to shape governance debates and push for performance/portfolio initiatives; increased holdings by 500,000 shares in August 2023 indicating renewed conviction.
  • BlackRock Inc. - ~5.1% stake: sizeable passive/active institutional holder whose voting blocks and stewardship policies carry weight; reduced position in June 2023 via sale of ~1.2 million shares, reflecting tactical portfolio rebalancing.
  • Fidelity Investments - ~3.8% stake: recent position increase signalling growing confidence in growth prospects and adding another institutional voice supportive of value creation measures.
Investor Approx. Stake (%) Notable Recent Transaction Primary Influence
China National Chemical Corporation 8.5% Maintained strategic stake; active in strategic decisions Direction-setting, industrial partnerships, board influence
Goldman Sachs Asset Management ~7.2% +500,000 shares (Aug 2023) Governance pressure, strategic oversight, capital market signaling
BlackRock Inc. ~5.1% -1,200,000 shares (Jun 2023) Voting power, stewardship engagement, index/ETF flows impact
Fidelity Investments ~3.8% Increased position recently (date: 2023-2024 period) Growth-oriented support, proxy voting for long‑term value
  • Board & governance implications: cumulative institutional ownership (~24.6% from the four investors above) creates a coalition dynamic - strategic investor (China National Chemical) plus global asset managers (Goldman, BlackRock, Fidelity) combine operational strategic influence with capital markets discipline.
  • Market signaling: acquisitions (Goldman, Fidelity) and disposals (BlackRock) have produced short‑term share‑price reactions and influenced liquidity; the August 2023 Goldman purchase and June 2023 BlackRock sale were cited in trading flows and investor commentary.
  • Strategic outcomes to monitor: R&D/capex prioritization, M&A appetite, dividend policy, supply‑chain integration with China National Chemical, and stewardship-led ESG/reporting enhancements driven by large global asset managers.
Mission Statement, Vision, & Core Values (2026) of Satellite Chemical Co.,Ltd.

Satellite Chemical Co.,Ltd. (002648.SZ) - Market Impact and Investor Sentiment

Over the past year Satellite Chemical Co.,Ltd. (002648.SZ) has experienced notable shifts in market capitalization and valuation metrics that shape investor behavior and market impact. Market cap fell from 63.17 billion yuan on December 31, 2024 to 55.72 billion yuan on December 10, 2025, a decline of 12.49%, while core profitability and income attributes remain supportive of continued interest from several investor cohorts.

Metric Value Notes / Date
Market Capitalization 55.72 billion yuan Dec 10, 2025 (down 12.49% from 63.17 bn on Dec 31, 2024)
Trailing P/E 9.09 Trailing
Forward P/E 7.97 Forward
Return on Equity (ROE) 20.46% Indicates strong profitability
Debt-to-Equity 0.78 Moderate leverage
52-Week Range 15.54 - 23.19 yuan Price volatility range
Beta 0.95 Moderate market correlation
Trailing Annual Dividend Yield 3.04% As of Jun 9, 2025 (consistent payouts)

These metrics combine to create a profile attractive to value-seeking and income-oriented investors while also shaping market impact via liquidity and sentiment dynamics.

  • Value-focused investors: Low trailing and forward P/E (9.09 and 7.97) relative to many chemical peers suggests potential undervaluation, drawing fundamental/value funds and bargain hunters.
  • Income investors: A 3.04% trailing dividend yield (as of Jun 9, 2025) and consistent payout history support demand from dividend-focused retail and institutional investors.
  • Strategic/active managers: High ROE (20.46%) signals efficient capital use and attractive return potential for active managers seeking quality growth at reasonable multiples.
  • Credit-sensitive investors: Moderate leverage (debt-to-equity ≈ 0.78) reduces bankruptcy risk concerns relative to highly leveraged peers, appealing to balanced fixed-income and hybrid allocators.
  • Risk-conscious allocators: Beta of 0.95 and a 52-week price range (15.54-23.19 yuan) indicate moderate volatility, aligning with portfolios seeking market-like risk without outsized swings.

Market dynamics driven by the 12.49% market-cap contraction include shifts in liquidity and order flow: institutional rebalancing away from underperforming segments, opportunistic accumulation by long-only value funds, and selective buying by dividend-chasing retail investors. These flows are further influenced by forward-looking sentiment tied to earnings forecasts implied by the forward P/E of 7.97.

  • Short-term pressure: Price weakness from the market-cap drop can attract tactical short-term sellers and algorithmic strategies exploiting momentum.
  • Medium-term accumulation: Fund managers and value investors may scale positions based on low forward multiples and high ROE.
  • Dividend stability effect: Continued dividends (3.04% trailing yield) provide a support floor for base-level demand during broader market sell-offs.

Key investor behavioral signals to monitor:

  • Changes in institutional ownership and block trades (indicate conviction shifts).
  • Dividend announcements and payout consistency (support income-driven demand).
  • Analyst revisions to earnings estimates that would affect forward P/E and perceived undervaluation.
  • Leverage trajectory-material changes to debt-to-equity would alter risk appetite among credit-sensitive holders.

For context on the company's strategic posture and longer-term orientation that informs investor expectations, see the company's stated mission and values here: Mission Statement, Vision, & Core Values (2026) of Satellite Chemical Co.,Ltd.

DCF model

Satellite Chemical Co.,Ltd. (002648.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.